Changeflow GovPing Healthcare Taking The Pulse Episode 273: Navigating FDA Re...
Routine Notice Added Final

Taking The Pulse Episode 273: Navigating FDA Regulation for Life Sciences Companies

Favicon for www.jdsupra.com JD Supra Healthcare
Published
Detected
Email

Summary

Maynard Nexsen published Episode 273 of its 'Taking The Pulse' healthcare and life sciences video podcast discussing FDA regulatory developments for life sciences companies. The episode features attorney Christin Carey covering tariffs affecting pharma and biotech, evolving FDA guidance for digital health and clinical decision support tools, and the agency's approach to AI, cybersecurity, and emerging technologies.

What changed

Maynard Nexsen published a healthcare podcast episode providing general regulatory commentary on FDA developments affecting life sciences companies. The episode discusses tariffs on pharma and biotech products, evolving FDA guidance for digital health and clinical decision support tools, and the agency's approach to AI, cybersecurity, and emerging technologies. The podcast offers industry perspective and informational content for legal and compliance professionals.

This content is informational commentary from a law firm and does not create compliance obligations. Life sciences companies, pharmaceutical manufacturers, and digital health companies seeking to understand FDA regulatory trends may find the episode useful for general awareness, but should consult primary FDA sources for binding requirements.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

April 14, 2026

Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 273: Navigating FDA Regulation for Life Sciences Companies with Christin Carey of Maynard Nexsen

Maynard Nexsen + Follow Contact LinkedIn Facebook X Send Embed Heather and Matthew welcome Christin Carey, Maynard Nexsen’s newest FDA-focused life sciences attorney, for a discussion on regulatory developments shaping the life sciences and digital health industries. Drawing on her extensive experience advising companies on FDA compliance and her recent in-house role at Amazon Health Services, Christin shares insight on new tariffs affecting pharma and biotech, evolving FDA guidance for digital health and clinical decision support tools, and the agency’s approach to AI, cybersecurity, and See more + Heather and Matthew welcome Christin Carey, Maynard Nexsen’s newest FDA-focused life sciences attorney, for a discussion on regulatory developments shaping the life sciences and digital health industries. Drawing on her extensive experience advising companies on FDA compliance and her recent in-house role at Amazon Health Services, Christin shares insight on new tariffs affecting pharma and biotech, evolving FDA guidance for digital health and clinical decision support tools, and the agency’s approach to AI, cybersecurity, and emerging technologies. Tune in for valuable guidance on navigating FDA regulation while developing innovative health products. See less -

Controls: true
Embed Copy Send Report

Latest Posts

Other MultiMedia by Maynard Nexsen

Work This Way, A Labor & Employment Podcast | No Tax on Tips: What Employers Need to Know with Brock Phillips of Maynard Nexsen
-

Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 272: Humanism and Transplant Care with Dr. Joseph Scalea of MUSC
-

Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 271: Advancing Neurotrauma Treatments with Ken Webb of NeuroHope Therapeutics
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 270: Building a Future-Ready Workforce in Life Sciences with Daniel Grove of Lonza
-

Work This Way: A Labor & Employment Law Podcast | “I Didn’t Touch Her”: Litigation Lessons from Cardi B’s Viral Trial with Malak Cherkaoui Jaouad of Maynard Nexsen
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 269: Investing in Distributed Healthcare with Gordon Maner of Frontline Healthcare Partners
-

Taking the Pulse: A Health Care and Life Sciences Video Podcast | Episode 268: Inside South Carolina’s Life Sciences Growth with James Chappell of SCbio
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 267: Leading Legal Strategy at a Growing Health System with Kelli Ferry of Novant Health
-

Work This Way: A Labor & Employment Law Podcast | Love and Liability: Navigating Workplace Romance with Bridget Blinn-Spears of Maynard Nexsen
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 266: Navigating Today’s Healthcare Landscape with Leighton Roper of Maynard Nexsen
-

Work This Way: A Labor & Employment Law Podcast | Service Animals, the ADA, and Workplace Rights
-

Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 264: 2026 Healthcare Industry Trends & Challenges with Lauren DeMoss and Matthew Roberts
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 263: Building NC's Innovation Ecosystem with Andrea Conner of First Flight Venture Center
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 262: Breaking the “Undruggable” Barrier with Marcel Frenkel of Ten63 Therapeutics
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 261: Transforming Lives with Advanced BioMaterials with Dr. Juliana Blum of BioAesthetics
-

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 260: Innovation and Policy in Animal Health with Ron Phillips of the Animal Health Institute
-

Work This Way: A Labor & Employment Law Podcast | Political Speech in the Workplace: What Employers Need to Know with Andrew Kragie of Maynard Nexsen
-

Project Catalyst: An Economic Development Podcast | Episode 18: The Triad’s Economic Momentum with Marvin Price of the Greensboro Chamber of Commerce
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.

©
Maynard Nexsen

Written by:

Maynard Nexsen Contact + Follow more less

PUBLISH YOUR CONTENT ON JD SUPRA

  • ✔ Increased readership
  • ✔ Actionable analytics
  • ✔ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra

Start Publishing »

Published In:

Business Organization + Follow Health + Follow more less

Maynard Nexsen on:

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign Up Log in ** By using the service, you signify your acceptance of JD Supra's Privacy Policy.* - hide - hide

Get daily alerts for JD Supra Healthcare

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Maynard Nexsen.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Maynard Nexsen
Published
April 14th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Pharmaceutical companies Technology companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 5112 Software & Technology
Activity scope
Regulatory commentary Industry podcast Professional education
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Pharmaceuticals Artificial Intelligence International Trade

Get alerts for this source

We'll email you when JD Supra Healthcare publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!